NCT05475028View on ClinicalTrials.gov

Network Medicine Approaches to Classify Heart Failure With PReserved Ejection Fraction by Signatures of DNA Methylation and Point-of-carE Risk calculaTors (PRESMET)

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 14, 2021

Primary Completion Date

January 14, 2022

Study Completion Date

June 14, 2022

Conditions
Heart Failure, DiastolicHeart Failure, SystolicPulmonary HypertensionAtrial Fibrillation
Interventions
OTHER

RRBS

Reduced Representation Bisulfite Sequencing

Trial Locations (1)

80138

University of Campania Luigi Vanvitelli, Naples

All Listed Sponsors
collaborator

Monaldi Hospital

OTHER

collaborator

Federico II University

OTHER

collaborator

University of Alabama at Birmingham

OTHER

lead

University of Campania Luigi Vanvitelli

OTHER

NCT05475028 - Network Medicine Approaches to Classify Heart Failure With PReserved Ejection Fraction by Signatures of DNA Methylation and Point-of-carE Risk calculaTors (PRESMET) | Biotech Hunter | Biotech Hunter